Skip to Main Content

Paper Details

LifeTime and improving European healthcare through cell-based interceptive medicine.
Nature
89
2020
cancer, human, human cells, infectious, chronic inflammatory and cardiovascular diseases, neurological and neuropsychiatric disorders, patient, single
Author NameAffiliation
Ido AmitWeizmann Institute of Science
Christoph BockCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Christoph BockLudwig Boltzmann Institute for Rare and Undiagnosed Diseases
Christoph BockMedical University of Vienna
Christoph BockCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Christoph BockMedical University of Vienna
Christoph BockLudwig Boltzmann Institute for Rare and Undiagnosed Diseases
Hans CleversHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW)
Hans CleversUniversity Medical Center Utrecht
Hans CleversOncode Institute
Hans CleversThe Princess Maxima Center for Pediatric Oncology
Angelika EggertBerlin Institute of Health (BIH)
Angelika EggertCharite-Universitatsmedizin Berlin
Jan Ellenberg
Jan Ellenberg
Susan M GasserFriedrich Miescher Institute for Biomedical Research
Susan M GasserUniversity of Basel
Norbert H??bnerCharite-Universitatsmedizin
Norbert H??bnerMax Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC)
Norbert H??bnerGerman Center for Cardiovascular Research (DZHK)
Norbert H??bnerBerlin Institute of Health (BIH)
Norbert H??bnerCharite-Universitatsmedizin
Norbert H??bnerBerlin Institute of Health (BIH)
Norbert H??bnerGerman Center for Cardiovascular Research (DZHK)
Norbert H??bnerMax Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC)
Juergen A KnoblichInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)
Juergen A KnoblichMedical University of Vienna
Peter LichterGerman Cancer Research Center (DKFZ)
Peter LichterGerman Cancer Research Center (DKFZ)
Sten LinnarssonKarolinska Institutet
Sten Linnarsson
John C MarioniEuropean Bioinformatics Institute
John C MarioniWellcome Sanger Institute
John C MarioniCancer Research UK Cambridge Institute, University of Cambridge
John C MarioniEuropean Bioinformatics Institute
John C MarioniCancer Research UK Cambridge Institute, University of Cambridge
John C MarioniWellcome Sanger Institute
Marc A Marti-RenomBarcelona Institute of Science and Technology
Marc A Marti-RenomBarcelona Institute of Science and Technology
Marc A Marti-RenomUniversitat Pompeu Fabra
Marc A Marti-Renom
Helen ParkinsonEuropean Bioinformatics Institute
Helen ParkinsonEuropean Bioinformatics Institute
Ana PomboBerlin Institute for Medical Systems Biology, Max Delbruck Center for Molecular Medicine in the Helmholtz Association
Ana PomboInstitute for Biology, Humboldt University of Berlin
Wolf ReikWellcome Sanger Institute
Wolf ReikBabraham Institute
Wolf ReikUniversity of Cambridge
Philip RosenstielInstitute of Clinical Molecular Biology, Kiel University
Philip RosenstielUniversity Hospital Schleswig-Holstein
  • 1 - 50

Datasets

Release 1.2